GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Avita 4735.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

35.55

+1.28%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 936.4m

FY2016FY2025

Net income

TWD 93.2m

FY2016FY2025

Free cash flow

−TWD 197.7m

FY2016FY2025

Shareholders' equity

TWD 996.0m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 936.4mTWD 927.3mTWD 879.1mTWD 1.20bnTWD 2.33bnTWD 2.60bnTWD 1.25bnTWD 1.33bnTWD 1.13bnTWD 1.10bn
Gross profitTWD 295.7mTWD 254.6mTWD 264.8mTWD 356.8mTWD 674.5mTWD 940.4mTWD 390.9mTWD 333.5mTWD 299.0mTWD 286.0m
Research and developmentTWD 93.0mTWD 76.1mTWD 87.6mTWD 73.4mTWD 70.7mTWD 59.0mTWD 51.7mTWD 46.8mTWD 40.8mTWD 33.7m
Operating incomeTWD 46.4mTWD 15.6mTWD 44.1mTWD 138.0mTWD 396.3mTWD 651.4mTWD 176.8mTWD 130.2mTWD 115.7mTWD 121.0m
Net incomeTWD 93.2mTWD 57.9mTWD 42.7mTWD 101.1mTWD 315.5mTWD 520.1mTWD 130.9mTWD 98.8mTWD 103.2mTWD 83.7m
Diluted earnings per share2.541.581.172.758.6613.773.572.692.812.48

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 1.35bnTWD 1.19bnTWD 1.24bnTWD 1.34bnTWD 1.69bnTWD 2.53bnTWD 1.04bnTWD 1.08bnTWD 982.3mTWD 825.3m
Cash and short-term investments——TWD 540.2mTWD 453.4mTWD 365.4mTWD 588.4m———TWD 171.3m
Total liabilitiesTWD 358.6mTWD 352.9mTWD 350.8mTWD 426.6mTWD 742.8mTWD 1.62bnTWD 515.7mTWD 656.2mTWD 537.2mTWD 376.3m
Debt——TWD 46.2mTWD 77.3mTWD 299.5mTWD 474.4mTWD 190.9mTWD 217.6mTWD 45.0mTWD 75.7m
Shareholders' equityTWD 996.0mTWD 838.1mTWD 888.3mTWD 911.2mTWD 952.0mTWD 909.4mTWD 525.5mTWD 422.8mTWD 445.1mTWD 449.0m
Shares outstanding37m37m37m37m36m38m37m37m37m34m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 64.5mTWD 192.5mTWD 212.0mTWD 490.5mTWD 237.0mTWD 406.3mTWD 231.8mTWD 107.8mTWD 160.6m—
Capital spending−TWD 262.2m−TWD 83.8m−TWD 31.3m−TWD 65.3m−TWD 71.9m−TWD 197.9m−TWD 44.4m−TWD 31.9m−TWD 118.8m—
Free cash flow−TWD 197.7mTWD 108.7mTWD 180.7mTWD 425.2mTWD 165.1mTWD 208.4mTWD 187.5mTWD 75.9mTWD 41.8m—
Dividends paid−TWD 89.6m−TWD 15.6m−TWD 54.9m−TWD 91.9m−TWD 298.8m−TWD 317.1m−TWD 71.6m−TWD 73.0m−TWD 65.2m—

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 273.4mTWD 214.9mTWD 248.0mTWD 236.3mTWD 253.5mTWD 198.5mTWD 208.5mTWD 269.2m
Gross profitTWD 80.6mTWD 71.2mTWD 75.4mTWD 79.7mTWD 79.8mTWD 60.8mTWD 63.6mTWD 88.9m
Operating incomeTWD 28.4mTWD 9.6mTWD 3.6m—TWD 25.4mTWD 4.9mTWD 5.9mTWD 29.0m
Net incomeTWD 122.4mTWD 45.9mTWD 28.0mTWD 35.1mTWD 19.8mTWD 10.3mTWD 20.8mTWD 19.8m
Diluted earnings per share3.341.250.760.960.540.280.570.54
Cash from operationsTWD 41.0m−TWD 12.0mTWD 42.0m−TWD 1.0mTWD 26.0m−TWD 2.0mTWD 129.0mTWD 46.0m
Capital spending−TWD 24.0m−TWD 16.0m−TWD 55.0m−TWD 113.0m−TWD 43.0m−TWD 49.0m−TWD 23.0m−TWD 57.0m
Free cash flowTWD 17.0m−TWD 28.0m−TWD 13.0m−TWD 114.0m−TWD 17.0m−TWD 51.0mTWD 106.0m−TWD 11.0m
Total assetsTWD 1.80bnTWD 1.52bnTWD 1.35bnTWD 1.32bnTWD 1.28bnTWD 1.39bnTWD 1.19bnTWD 1.35bn
Shareholders' equityTWD 1.13bnTWD 1.03bnTWD 996.0mTWD 973.8mTWD 915.0mTWD 1.02bnTWD 838.1mTWD 858.7m

Financial ratios

Data as of 5 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Gross margin31.6%27.5%30.1%29.7%29.0%36.2%——
Operating margin10.1%6.3%5.0%11.5%17.0%25.1%——
Net margin10.0%6.2%4.9%8.4%13.6%20.0%——
Return on equity9.4%6.9%4.8%11.1%33.1%57.2%——
Return on assets6.9%4.9%3.4%7.6%18.6%20.5%——
Free cash flow yield—21.0%18.5%42.1%23.6%44.5%——
Revenue growth1.0%5.5%-26.8%-48.4%-10.6%108.4%——
Earnings growth61.0%35.5%-57.8%-67.9%-39.3%297.2%——
Current ratio1.90x2.05x2.24x2.02x1.56x1.22x——
Debt to equity——0.05x0.08x0.31x0.51x0.36x0.51x
Equity ratio73.5%70.4%71.7%68.1%56.2%35.9%——
Interest coverage201.60x15.83x15.40x87.91x89.21x260.58x——
R&D as a share of sales9.9%8.2%10.0%6.1%3.0%2.3%——
Buybacks as a share of market value—-0.3%0.4%-0.8%3.5%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-8.0%-18.5%-1.2%
Operating income-30.5%-41.1%-5.9%
Net income-2.7%-29.1%4.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin29.5%29.7%31.4%29.5%
Operating margin3.3%6.2%14.6%13.0%
Net margin8.1%7.5%12.7%10.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings12.625.131.514.36.87.413.214.418.014.3
Price to sales1.31.61.51.20.91.51.41.11.61.1

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 15 Jun 2026.

FY2026FY2025FY2024FY2023FY2022
Paid in the year1.502.3080.451.502.50

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.